Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study
Bruno Fattizzo(University of Milan), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Henrik Frederiksen(University of Southern Denmark), Josephine M. I. Vos(Sanquin), Andrea Patriarca(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Francesco Zaja, Marc Michel(Université Paris-Est Créteil), S. Guillet(Assistance Publique – Hôpitaux de Paris), Juri Alessandro Giannotta(University of Milan), Bernd Jilma(Medical University of Vienna), Anna Zaninoni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Anita Hill(Leeds General Infirmary), Francesca Romana Mauro(Sapienza University of Rome)
Cited by 66
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|578
Thrombosis in paroxysmal nocturnal hemoglobinuria
|Blood|2013|474